Trexquant Investment LP Catalyst Biosciences, Inc. Transaction History

Trexquant Investment LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$3.78 - $5.18 $121,791 - $166,899	-32,220 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$4.1 - $5.33 $132,102 - $171,732	32,220 New	32,220 $140,000
Q4 2020 Feb 11, 2021	SELL	$4.55 - $7.29 $344,371 - $551,750	-75,686 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$4.22 - $6.04 $89,696 - $128,380	21,255 Added 39.05%	75,686 $325,000
Q2 2020 Aug 07, 2020	BUY	$3.76 - $8.01 $204,660 - $435,992	54,431 New	54,431 $320,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.